1.Formulation and Analysis on the Standard of Automation and Information Technology
Xun YU ; Jiancun ZHEN ; Liyan MIAO ; Zongqi CHENG ; Wei ZHANG ; Rongsheng ZHAO ; Lan ZHANG ; Xiaoyang LU ; Jian ZHANG ; Dong LIU ; Aizong SHEN ; Weihua LAI ; Jingcheng HE
Herald of Medicine 2024;43(7):1074-1078
		                        		
		                        			
		                        			To improve patient-centered pharmaceutical management and pharmaceutical service capabilities in the pharmaceutical department of medical institutions,automation and information technology are indispensable.The Pharmacy Administration-Automation and Information Technology is one of the social organization standards of the Chinese Hospital Association as part 4-4 of Pharmaceutical Administration and Pharmaceutical Practice in Healthcare,which standardizes 32 key elements in four aspects:basic requirements for automation construction in medical institutions,construction of automation hardware equipment,construction of intelligent information platform,and quality management and continuous improvement.It can be used to guide medical institutions at all levels to select and optimize pharmacy automation equipment and information platforms.This article introduced the construction methods and contents of the pharmacy automation and information technology standards,to deepen the understanding of peers on this standard and promote its implementation.This article aimed to promote the modernization,informatization,and intelligence of pharmaceutical services in medical institutions,and improve the quality and efficiency of overall medical pharmaceutical administration and service.
		                        		
		                        		
		                        		
		                        	
2.Coronavirus disease 2019 in pregnant and non-pregnant women: a retrospective study.
Ying ZHA ; Ge CHEN ; Xun GONG ; Yuan-Yuan WU ; Xing-Guang LIN ; Jian-Li WU ; Ya-Fei HUANG ; Yu-Qi LI ; Ying ZHANG ; Dong-Rui DENG ; Su-Hua CHEN ; Fu-Yuan QIAO ; Ling FENG ; Wan-Jiang ZENG ; Ke-Zhen LI ; Hai-Yi LIU
Chinese Medical Journal 2021;134(10):1218-1220
3.New Thoughts for Development of Tibetan Medicine of Ganzi Tibetan Autonomous Prefecture
Lei LI ; Hai-Yan GUO ; Yan ZHEN ; Chun-Yu HU ; Jian-Xun LIU
Chinese Journal of Information on Traditional Chinese Medicine 2018;25(3):12-15
		                        		
		                        			
		                        			Ganzi Tibetan Autonomous Prefecture is the birthplace of Tibetan medicine of southern school, also rich in natural resources of Chinese and Tibetan medicine (CTM). As the pillar industry of Ganzi prefecture, CTM shows a trend of improvement of overall services, growing of the number of companies and increasing scale of industries. However, the CTM industry in Ganzi prefecture still has some shortcomings. This article reviewed the development and existential problems of CTM industry of Ganzi prefecture. In addition, the article carries on relevant thinking through literature review and discussion and analysis. It is believed that CTM industry of Ganzi prefecture faced with the conflict between environmental protection and the development of CTM industry, small scale of CTM industry, inadequate expertise and insufficient product innovation. This article gave some feasible suggestions, such as coordinated development of cultural tourism and medical industry, establishment of high efficient mode to promote producing-learning-research development, enhancement of quality standardization of CTM industry, with a purpose to guarantee the quality transmission of each step.
		                        		
		                        		
		                        		
		                        	
4.Relationship between two blood stasis syndromes and inflammatory factors in patients with acute coronary syndrome.
Cai-Yun MA ; Jing-Hua LIU ; Jian-Xun LIU ; Da-Zhuo SHI ; Zhen-Ye XU ; Shao-Ping WANG ; Min JIA ; Fu-Hai ZHAO ; Yue-Rong JIANG ; Qin MA ; Hong-Yu PENG ; Yuan LU ; Ze ZHENG ; Feng-Xue REN
Chinese journal of integrative medicine 2017;23(11):845-849
OBJECTIVETo investigate the relationship between inflammatory factors and two Chinese medicine (CM) syndrome types of qi stagnation and blood stasis (QSBS) and qi deficiency and blood stasis (QDBS) in patients with acute coronary syndrome (ACS).
METHODSSixty subjects with ACS, whose pathogenesis changes belongs to qi disturbance blood stasis syndrome, were divided into 2 groups: 30 in the QSBS group and 30 in the QDBS group. The comparative analysis on them was carried out through comparing general information, coronary angiography and inflammatory factors including intracellular adhesion molecule-1 (ICAM-1), chitinase-3-like protein 1 (YKL-40) and lipoprotein-associated phospholipase A2 (Lp-PLA2).
RESULTSCompared with the QSBS group, Lp-PLA2 and YKL-40 levels in the QDBS group showed no-significant difference (P>0.05); ICAM-1 was significantly higher in the QDBS group than in the QSBS group in the pathological processes of qi disturbance and blood stasis syndrome of ACS (P<0.05).
CONCLUSIONSInflammatory factor ICAM-1 may be an objective basis for syndrome typing of QSBS and QDBS, which provides a research direction for standardization research of CM syndrome types.
5.Effect of rhG-CSF Mobilization on S1P5 Expression in T Lymphocyte Subsets of Allo-HSCT Donors.
Meng LI ; Li-Xun GUAN ; Zhen-Yang GU ; Sha-Sha ZHAO ; Fei-Yan WANG ; Hua-Ping WEI ; Li WANG ; Hong-Hua LI ; Jian BO ; Chun-Ji GAO
Journal of Experimental Hematology 2016;24(4):1132-1136
OBJECTIVETo explore the effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) mobilization on S1P5 expression in T lymphocyte subsets of allo-HSCT donors.
METHODSThe peripheral blood was collected from 10 allo-hematopoietic stem cell transplantation (allo-HSCT) donors before and after mobilization with rhG-CSF for 4 days. The flow cytometry was used to detect S1P5 expression in T lymphocyte subsets.
RESULTSThere was no S1P5 expression on the surface of T-lymphocytes both before and after rhG-CSF mobilization. After fixation with permeabilization agent, S1P5 expression could be detected in lymphocytes after rhG-CSF mobilization, which indicates S1P5 may be located in cells. Compared with level before rhG-CSF mobilization, S1P5 expression was significantly increased in T lymphocyte subsets after rhG-CSF mobilization, CD3(+)T cells (57.92±2.32)% vs (7.94±1.47)%(P<0.05), CD4(+)T cells (72.58±1.73)% vs (5.48±0.82)%(P<0.05), CD8(+)T cells(51.79±3.57)% vs (6.46±1.01)%(P<0.05),CD3-/CD56(+)NK cells(40.00±1.47)% vs(4.97±0.74)%(P<0.05). The up-regulated level of S1P5 expression in CD4(+)T cells was most high(P<0.05).
CONCLUSIONS1P5 expression significantly increases in T lymphocyte subsets after rhG-CSF mobilization, and the up-regulated level of S1P5 expression in CD4(+)T cells is the most high.
Flow Cytometry ; Granulocyte Colony-Stimulating Factor ; Hematopoietic Stem Cell Transplantation ; Humans ; Receptors, Lysosphingolipid ; Recombinant Proteins ; T-Lymphocyte Subsets ; Transplantation, Homologous
6.Correlation between Constitution of Yin Deficiency Syndrome and Polymorphism of HLA-DQA1/Treatment Response of Peg-IFNalpha Therapy in HBeAg Positive Chronic Hepatitis B Patients.
Jian-chun GUO ; Xiao-mei DENG ; Jing WU ; Yun-hao XUN ; Xiao-xiao HUANG ; Wei-wei WANG ; Wei-zhen SHI
Chinese Journal of Integrated Traditional and Western Medicine 2016;36(5):539-543
OBJECTIVETo observe the correlation between constitution of yin deficiency syndrome (YDS) and polymorphism of HLA-DQA1/treatment response of Peg-lFNalpha therapy in HBeAg positive chronic hepatitis B (CHB) patients, and to explore constitution of Chinese medicine (CM) in response of interferon therapy.
METHODSTotally 120 HBeAg positive CHB patients who were treated with Peg-IFNalpha were enrolled, and assigned to YDS group (59 cases) and non-YDS group (61 cases) according to classification of CM constitutions. All patients were subcutaneously injected with Peg-IFNalpha-2b (1.0 microg/kg body weight) or Peg-IFNalpha-2a (180 microg), once per week. Effective efficacy was primarily judged when complete response (CR) or partial response (PR) was obtained at month 6. Those with CR or PR completed 1 year therapeutic course. HLA-DQA1 gene types were detected by polymerase chain reaction sequence specific primers (PCR-SSP). The distribution difference of CM constitutions in patients with CR or PR and their inter-group HLA-DQA1 allele frequency were compared.
RESULTSDifferent treatment responses of Peg-IFNalpha were observed in CHB patients of two different CM constitutions. The ratio of CR + PR was 61.0% (36/59) in YDS group, obviously lower than that in NYDS group [78.7% (48/61), P < 0. 05]. Patients with CR had a lower allele frequency of HLA-DQA1 * 0501 than those with no-response [14.8% (8/54) vs. 30.6% (22/72)] with statistical difference (P < 0.05). Patients with CR had a higher allele frequency of HLA-DQA1 * 0601 than those with no-response [18.5% (10/54) vs. 5.6% (4/72)] with statistical difference (P < 0.05). The allele frequency of HLA-DQA1 * 0301 was lower in YDS group than in non-YDS group [2. 5% (3/118) vs. 9.8% (12/122)] with statistical difference (P < 0.05). The allele frequency of HLA-DQA1 * 0501 was higher in YDS group than in non-YDS group [33.9% (40/118) vs. 18.9% (23/122)] with statistical difference (P < 0.05). Yet statistical significance was lost after adjustment (Pc > 0.05 for both).
CONCLUSIONSBoth constitutions of CM and HLA-DQA1 gene polymorphism af- fect HBeAg positive CHB patients' response to Peg-INFalpha. Constitutions of YDS and HLA-DQA1 * 0501 was not favorable to response, their association needed to be further studied.
Antiviral Agents ; therapeutic use ; Gene Frequency ; HLA-DQ alpha-Chains ; genetics ; Hepatitis B e Antigens ; blood ; Hepatitis B, Chronic ; drug therapy ; genetics ; Humans ; Interferon-alpha ; therapeutic use ; Medicine, Chinese Traditional ; Polyethylene Glycols ; therapeutic use ; Polymorphism, Genetic ; Recombinant Proteins ; therapeutic use ; Remission Induction ; Yin Deficiency ; genetics
7.Managing esophageal fistulae by endoscopic transluminal drainage in esophageal cancer patients with superior mediastinal sepsis after esophagectomy.
Yu-Zhen ZHENG ; Shu-Qin DAI ; Hong-Bo SHAN ; Xiao-Yan GAO ; Lan-Jun ZHANG ; Xun CAO ; Jian-Fei ZHU ; Jun-Ye WANG
Chinese Journal of Cancer 2013;32(8):469-473
		                        		
		                        			
		                        			The management of postoperative leaks into the mediastinum after esophagectomy remains a challenge. We describe our clinical management of this complication through endoscopic transluminal drainage. Between 2008 and 2011, 4 patients with esophageal squamous cell carcinoma (ESCC) who underwent McKeown-type esophagectomy with two-field lymphadenectomy experienced complicated anastomotic fistulae in the presence of superior mediastinal sepsis. All 4 patients underwent endoscopic transluminal drainage, and all survived. The mean healing period was 50 days (range, 31 to 58 days), the mean stay in the intensive care unit was 7.3 days (range, 1 to 18 days), and the mean hospital stay was 64.5 days (range, 49 to 70 days). Endoscopically guided transluminal drainage should be considered for ESCC patients with superior mediastinal fistulae after esophagectomy.
		                        		
		                        		
		                        		
		                        			Aged
		                        			;
		                        		
		                        			Carcinoma, Squamous Cell
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Drainage
		                        			;
		                        		
		                        			Endoscopy
		                        			;
		                        		
		                        			Esophageal Fistula
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			therapy
		                        			;
		                        		
		                        			Esophageal Neoplasms
		                        			;
		                        		
		                        			surgery
		                        			;
		                        		
		                        			Esophagectomy
		                        			;
		                        		
		                        			adverse effects
		                        			;
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Lymph Node Excision
		                        			;
		                        		
		                        			Male
		                        			;
		                        		
		                        			Mediastinum
		                        			;
		                        		
		                        			Middle Aged
		                        			;
		                        		
		                        			Sepsis
		                        			;
		                        		
		                        			etiology
		                        			;
		                        		
		                        			therapy
		                        			
		                        		
		                        	
8.Tenidap is neuroprotective in a pilocarpine rat model of temporal lobe epilepsy.
Xing-Hua TANG ; Xun-Yi WU ; Lan XU ; You-Xin FANG ; Jian-Hong WANG ; Guo-Xing ZHU ; Zhen HONG
Chinese Medical Journal 2013;126(10):1900-1905
BACKGROUNDTenidap is a liposoluble non-steroidal anti-inflammatory drug that is easily distributed in the central nervous system and also inhibits the production and activity of cyclooxygenase-2 (COX-2) and cytokines in vitro. This study aimed to evaluate the neuroprotective effect of tenidap in a pilocarpine rat model of temporal lobe epilepsy (TLE).
METHODSTenidap was administered daily at 10 mg/kg for 10 days following pilocarpine-induced status epilepticus (SE) in male Wistar rats after which prolonged generalized seizures resulted in TLE. After tenidap treatment, spontaneous recurrent seizures (SRSs) were recorded by video monitoring (for 7 hours per day for 14 days). The frequency and severity of the SRSs were observed. Histological and immunocytochemical analyses were used to evaluate the neuroprotective effect of tenidap and detect COX-2 expression, which may be associated with neuronal death.
RESULTSThere were 46.88 ± 10.70 survival neurons in tenidap-SE group, while there were 27.60 ± 5.18 survival neurons in saline-SE group at -2.4 mm field in the CA3 area. There were 37.75 ± 8.78 survival neurons in tenidap-SE group, while there were 33.40 ± 8.14 survival neurons in saline-SE group at -2.4 mm field in the CA1 area. Tenidap treatment significantly reduced neuronal damage in the CA3 area (P < 0.05) and slightly reduced damage in the CA1 area. Tenidap markedly inhibited COX-2 expression in the hippocampus, especially in the CA3 area.
CONCLUSIONTenidap conferred neuroprotection to the CA3 area in a pilocarpine-induced rat model of TLE by inhibiting COX-2 expression.
Animals ; Cyclooxygenase 2 ; metabolism ; Epilepsy, Temporal Lobe ; chemically induced ; drug therapy ; metabolism ; Indoles ; therapeutic use ; Male ; Neuroprotective Agents ; therapeutic use ; Pilocarpine ; toxicity ; Rats ; Rats, Wistar
9.Clinical research of the relation of hepatitis B surface antigen (HBsAg) quantification and hepatic tissue pathological staging
Xiu-Li YU ; Jian-Chun GUO ; Yun-Hao XUN ; Wei-Zhen SHI ; Yu-Fang WANG ; Wei-Wei WANG ; Wei LIU
Chinese Journal of Experimental and Clinical Virology 2013;27(1):44-46
		                        		
		                        			
		                        			Objective To explore the correlation of serum hepatitis B surface antigen (HBsAg)level and hepatic tissue pathological staging in the chronic hepatitis B infected persons.Methods Collect the clinical data of 272 cases who are HBsAg-positive more than 6 months and accepted hepatic biopsy in our hospital.Detect serum HBsAg quantification,ALT,HBV DNA,complete blood count,hepatic tissue pathological staging,grouping the cases according to the stage of inflammation and the fibrosis degree respectively.Observe serum HBsAg quantification,HBV DNA and the stage of inflammation and the fibrosis degree.Analyse the correlation between HBsAg quantification and HBV DNA.Results The correlation of serum HBsAg level and HBV DNA is notable.Serum HBsAg level is a variable affecting hepatic tissue pathological stage significantly.Conclusions Serum HBsAg level is a marker having higher specificity and sensitivity to diagnose the hepatic fibrosis.
		                        		
		                        		
		                        		
		                        	
10.Value of delta model for end-stage liver disease in evaluating the prognosis of liver failure natients with hepatitis B virus
Jian-Chun GUO ; Chun-Qing LI ; Yun-Hao XUN ; Yu-Fang WANG ; Xiu-Li YU ; Wei-Zhen SHI ; Jun-Ping SHI ; Cuo-Qiang LOU
Chinese Journal of Experimental and Clinical Virology 2012;26(1):48-50
		                        		
		                        			
		                        			Objective To evaluate the prognostic value of the model for end-stage liver disease (MELD) and △MELD in liver failure patients infected with hepatitis B virus.Methods Based on prospective study design,98 hospitalized cases were studied and followed up for 24 weeks.The clinical data were recorded.We calculated the score of MELD and △MELD,and also compare the score between the survival group and death group.Using ROC curve plotting obtained the better decisive threshold.The case fatality rate were compared at different time points which the patients were classified by the best critical value of MELD and △MELD.We draw the Kaplan-Meier survival curve of different group and analyse the change of survival rate by log-rank analysis.Results 52 of 97 patients died and 46 survive during 24 weeks of followup.There was significant difference between the two groups for MELD and △MELD (P < 0.01 ).The case fatality rate in group which MELD ≥ 23 was obviously higher than in that MELD < 23. The rate in group which △MELD >4.5 was obviously higher than in that △MELD < 4.5 (P < 0.001 ).The area under curve (AUC) for the twelfth and 24th week' s prognosis judgment of △MELD(0.823,0.815) was larger than that of MELD ( 0.680,0.684 ) ( P < 0.05 ).Survival analyses (Kaplan-Meier) indicated that there were significant differences in cumulative survival rates among the groups which were grouped by optimization critical value(P =0.000).Conclusions The scoring system of MELD also applied to the forecasting of prognosis for severe hepatitis B patients in China.The accuracy of △MELD to predict the prognosis was higher than that of MELD.The combination of MELD and △MELD showed good clinical practical value.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail